NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free MLSS Stock Alerts $0.56 +0.02 (+3.72%) (As of 04/23/2024 ET) Add Compare Share Share Today's Range$0.55▼$0.5850-Day Range$0.54▼$0.7852-Week Range$0.52▼$1.35Volume43,424 shsAverage Volume98,884 shsMarket Capitalization$42.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Get Milestone Scientific alerts: Email Address Ad InvestorPlaceElon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake. About Milestone Scientific Stock (NYSE:MLSS)Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Read More MLSS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MLSS Stock News HeadlinesApril 24, 2024 | americanbankingnews.comMilestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.comApril 16, 2024 | americanbankingnews.comStockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS)April 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...April 3, 2024 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, FloridaApril 2, 2024 | msn.comMilestone Scientific Inc. (AMEX:MLSS) Q4 2023 Earnings Call TranscriptApril 2, 2024 | finance.yahoo.comQ4 2023 Milestone Scientific Inc Earnings CallApril 1, 2024 | globenewswire.comMilestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023March 31, 2024 | markets.businessinsider.comMilestone Scientific earnings preview: what to expectApril 24, 2024 | InvestorPlace (Ad)Elon Musk’s Controversial New Project: “Apollo”Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...March 28, 2024 | globenewswire.comMilestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference CallMarch 21, 2024 | thestreet.comMilestone Scientific Inc.March 17, 2024 | investing.comMilestone Scientific begins sales to Omaha clinicMarch 14, 2024 | globenewswire.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain PhysiciansFebruary 28, 2024 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System with Meridian Endo & PerioFebruary 28, 2024 | markets.businessinsider.comMilestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & PerioFebruary 28, 2024 | globenewswire.comMilestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & PerioFebruary 20, 2024 | finance.yahoo.comMilestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the NortheastFebruary 20, 2024 | globenewswire.comMilestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the NortheastFebruary 15, 2024 | finance.yahoo.comMilestone Scientific Inc. (MLSS)January 16, 2024 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement UpdateJanuary 16, 2024 | finance.yahoo.comMilestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement UpdateDecember 13, 2023 | finance.yahoo.comMilestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common StockDecember 11, 2023 | msn.comMilestone Scientific prices capital raise of $3.0 million via stock offeringDecember 10, 2023 | finance.yahoo.comMilestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common StockDecember 8, 2023 | msn.comMilestone Scientific announces proposed public offering of common stockDecember 8, 2023 | finance.yahoo.comMilestone Scientific Inc. Announces Proposed Public Offering of Common StockDecember 8, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation ProceduresSee More Headlines Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/29/2024Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryN/A Current SymbolNYSE:MLSS CUSIPN/A CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees17Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,930,000.00 Net Margins-70.50% Pretax Margin-71.04% Return on Equity-86.72% Return on Assets-61.08% Debt Debt-to-Equity RatioN/A Current Ratio3.51 Quick Ratio2.65 Sales & Book Value Annual Sales$9.83 million Price / Sales4.34 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book5.06Miscellaneous Outstanding Shares76,602,000Free Float57,298,000Market Cap$42.67 million OptionableOptionable Beta0.98 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Jan Adriaan Haverhals (Age 62)President, CEO & Director Comp: $680.26kMr. Leonard A. Osser (Age 77)Founder & Vice Chairman Mr. Andy Molnar (Age 62)Senior Vice President of Global Sales & Business Development for Dental Keisha HarcumControllerKey CompetitorsReWalk RoboticsNASDAQ:LFWDVicarious SurgicalNYSE:RBOTNutribandNASDAQ:NTRBCollPlant BiotechnologiesNASDAQ:CLGNEnvoy MedicalNASDAQ:COCHView All CompetitorsInstitutional OwnershipCarnegie Capital Asset Management LLCSold 19,660 shares on 1/30/2024Ownership: 0.158%View All Institutional Transactions MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed in 2024? Milestone Scientific's stock was trading at $0.6899 at the beginning of 2024. Since then, MLSS shares have decreased by 19.2% and is now trading at $0.5571. View the best growth stocks for 2024 here. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) announced its earnings results on Friday, March, 29th. The company reported ($0.03) EPS for the quarter. The business had revenue of $2.26 million for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative trailing twelve-month return on equity of 86.72%. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:MLSS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm PressThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
